THE EFFECT OF INJECTION OF INTRA ARTICULAR ALLOGENIC BONE MARROW MESENCHYMAL STEM CELL-PLATELET CELL RICH PLASMA (BMSCs-PRP) ON FULL-THICKNESS ARTICULAR CARTILAGE DEFFECT REGENERATION IN RABBIT
Downloads
The joint cartilage defectfullthickness is still a problem today because its currenttreatment still has not delivered maximum results. Current treatment uses cartilage enginering using mesenchymal stem cells alone and or combining growth factor. The aim of this study was to investigate the effect of intra-articular injection of Allogenic bone marrow mesenchymal stem cell - Platelet rich plasma (BMSCs-PRP) on regeneration of cartilage defect fullthickness in rabbits. The design of this study was a post-test only control group design using 36 New Zealand white rabbits divided into three groups. Each group were treated with PRP, BMSCs and BMSCs-PRP. Results were evaluated after 10 weeks. In the evaluation, macroscopic images showed the best healing in the BMSCs-PRP group. Histopathologic examination showed that in the MSCs-PRP group, there was a significant increase in the number of chondrocytes (p = 0,000), cartilage area (p = 0,000), as well as the number of Agecoprogenitorexpec- tion cells (p = 0,000) and collagen type 2 (p = 0,000). BMSCs were able to differentiate into condroblasts which then synthesize aggressive and collagen type 2. Platelet rich plasma (PRP) contains growth factor BMP, TGF, FGF and IGF which can accelerate the occurrence of MSCs differentiation. Intra-articular injections Allogenic bone marrow mesenchymal stem cell (BMSCs-PRP) is able to regenerate and cure full-thickness joint cartilage defects through differentiation of MSCs into condroblasts.
Keyword: Allogenic, Bone marrow Mesenchymal stem cell, Cartilage, Platelet rich plasma, Full-thickness.Aroen A, Loken S, Heir S, Alvik E, Ekeland A, Granlund O G, Engebretsen L. Articular Cartilage Lesions in 993 Consecutive Knee Arthroscopies.American Journal of Sports Medicine, 2004 (32): 211-215.
Akeson W, Amiel D, Gershuni D. Articular cartilage physiology and metabolism. In: Resnick D, ed. Diagnosis of bone and joint disorders. Philadelphia: WB Saunders, 1994:23-1-23-31.
Athanasiou KA, Shah AR and Hernandez RJ. Basic Science of Articular Cartilage Repair. J. Clin Sport Me, 2002; 39(4):223 – 47.
Benninghoff A. Form und bau der Geleknorpel in ihren Bezeihungen zur Funktion. Z Zellforsch Mikrosk Anat 2, 1925: 783-825.
Buckwalter JA, Mankin HJ and Grodzinsky AJ. Articular cartilage and osteoarthritis. Instr Course Lect, 2005; 54: 465–80.
Bunnell BA, Kluge KA, Lee-Lin SQ, et al. Transplantation of transduced nonhuman primate CD34 cells using a gibbon ape leukemia virus vector: restricted expression of the gibbon ape leukemia virus receptor to a subset of CD34 cells. Gene Ther, 1999; 6: 48-56
Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cellular Biochem, 2006; 98: 1076-1084.
Caplan AI. Review: mesenchymal stem cells: cell-based reconstructive therapy in orthopedics. Tissue Eng, 2005; 11(7-8): 1198-211.
Chen FH, Song Li, Mauck RI and Li WJ. Mesenchymal Stem Cells. In:Lanza R, Langer R, Vacanti J eds. Principles of Tissue Engineering. 3rd Edition.
Chen H, Sun J, Hoemann CD, et al. Drilling and microfracture lead to different bone structure and necrosis during bone-marrow stimulation for cartilage repair. J Orthop Res, 2009; 27(11): 1432- 8.
Clutterbuck AL, Asplin KE, Harris P, Allaway D, Mobasheri A. Targeting matrix metalloproteinases in inflammatory conditions. Curr Drug Targets, 2009; 10(12): 1245-54.
Cook SD, Barrack RL and Skinner HB. Basic Science in Orthopaedic Surgery, In Skinner HB, ed. Current Diagnosis and Treatment in Orthopaedics. 2nded. New York : Lange Medical Book, 2000: 8 – 11.
Darmadi SH. Mechanism of Cartilage Healing.Surabaya : Lab/SMF Orthopaedi dan Traumatologi FK Unair / RSUD Dr. Soetomo, 2002.
Gregory JS, Waarsing JH, Day J, Pols HA, Reijman M., Weinans H and Aspden RM. Early identification of radiographic osteoarthritis of the hip using an active shape model to quantify changes in bone morphometric features: can hip shape tell us anything about the progression of osteoarthritis? Arthritis Rheum, 2007; 56: 3634–3643.
Gobbi A and Bathan L. Biological Approach for Cartilage Repair.J Knee Surg, 2009; 2: 36–44.
Gupta PK, Das AK, Chulikana A and Majumdar AS.(2012) Mesenchymal stem cells for cartilage repair in osteoarthritis. Stem cell & Therapy. 3: 25.
Henderson JH, Welter JF, Mansour JM, Niyibizi C, Caplan, A. I., and Dennis, J. E. Cartilage tissue engineering for laryngotracheal reconstruction: comparison of chondrocytes from three anatomic locations in the rabbit. Tissue Eng, 2007; 13(4): 843-53
Iliz MZ, Mok MT, Williamson OD, Campbell MA, Hughes CE, Handley CJ. Catabolism of aggrecan by explant cultures of human articular cartilage in the presence of retinoic acid. Arch Biochem Biophys, 1995: 322(1); 22-30.
Im GI, Kim DY, Shin JH, Hyun CW, Cho WH. Repair of cartilage defect in the rabbit with cultured mesenchymal stem cells from bone marrow. J Bone Joint Surg Br, 2001; 83: 289-294.
Khan WS, Adesida AB, Hardingham TE. Hypoxic conditions increase hypoxia-inducible transcription factor 2alpha and enhance chondrogenesis in stem cells from the infrapatellar fat pad of osteoarthritis patients. Arthtitis research & therapy, 2005; 9: R55.
Koga H, Engebretsen L, Brinchmann JE, Muneta T and Sekiya K. Mesenchymal stem cell-based therapy for cartilage repair: a review. 2009; 17: 1289 – 97.
Lewthwaite J, Blake S, Thompson RC, et al. Antifibrotic action of interleukin-1 receptor antagonist in lapine monoarticular arthritis. Ann Rheum Dis, 1995; 54: 591-596.
Magnussen RA, Dunn WR, Carey JL, Spindler KP. Treatment of focal articular cartilage defects in the knee: a systematic review. Clin Orthop Relat Res, 2008; 466: 952-962.
Mankin HJ, Buckwaller JA, Grodzinsky AJ. Articular cartilage and osteoarthritis. Inst Course Lect, 2005; 54: 465-480.
Muschler GF, Nakamoto C, Griffith LG. Engineering principles of clinical cell-based tissue engineering. J Bone Joint Surg. Am., 2004: 86-A; 1541-1558.
McIlwraith CW, Frisbie DD, Rodkey WG, Kisiday JD, Werpy NM, Kawcak CE, Steadman JR. Evaluation of intra-articular mesenchymal stem cells to augment healing of microfractured chondral defects. Arthroscopy, 2011 Nov; 27(11): 1552-61.
Nejadnik H, Hui JH, Feng Choong EP, et al. Autologous bone marrow-derived mesenchymal stem cells versus autologous chondrocyte implantation: an observational cohort study. Am J Sports Med, 2010; 38: 1110-1116.
Punwar S, Khan WS. Mesenchymal Stem Cells and Articular Cartilage Repair: Clinical Studies and Future Direction. Open Orthop J, 2011; 5: 296-301
Redman SN, Oldfield SF and Archer CW. (2005) Current strategies for articular cartilage repair. Eur Cell Mater, 2005 Apr 14; 9: 23 – 32.
Rofi'i dan Dwikora NU.(2011) Optimal Consentrasion Platelet rich plasma and growth factor with varius sentrifugation technique.Tesis, UniversitasAirlangga.
Sato M, Uchida K, Nakajima H, Miyazaki T, Guerrero AR, Watanabe S, Roberts S, Baba H. Direct transplantation of mesenchymal stem cells into the knee joints of hartley strain guinea pigs with spontaneous osteoarthritis. Arthritis Res Ther, 2012; 14:R31.
Sharma B, Williams CG, et al. Designing zonal organization into tissue-engineered cartilage. Tissue Eng, 2007; 13(2): 405-414
Sun Y, Lu Y, Chen S, Prasad M, Wang X, Zhu Q, Zhang J, et al. Key proteolytic cleavage site and full-length form of DSPP. J Dent Res, 2010; 89: 498-503.
Wakitani S, Goto T, Pineda SJ, Young RG, Mansour JM, Caplan AI, Goldberg VM. Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage. J Bone Joint Surg Am, 1994; 76: 579-592.
Whitman DH, Berry RL, Green DM. Platelet gel: an autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Maxillofac Surg, 1997; 55(11): 1294-1299.
1. As an author you (or your employer or institution) may do the following:
- make copies (print or electronic) of the article for your own personal use, including for your own classroom teaching use;
- make copies and distribute such copies (including through e-mail) of the article to research colleagues, for the personal use by such colleagues (but not commercially or systematically, e.g. via an e-mail list or list server);
- present the article at a meeting or conference and to distribute copies of the article to the delegates attending such meeting;
- for your employer, if the article is a ‘work for hire', made within the scope of your employment, your employer may use all or part of the information in the article for other intra-company use (e.g. training);
- retain patent and trademark rights and rights to any process, procedure, or article of manufacture described in the article;
- include the article in full or in part in a thesis or dissertation (provided that this is not to be published commercially);
- use the article or any part thereof in a printed compilation of your works, such as collected writings or lecture notes (subsequent to publication of the article in the journal); and prepare other derivative works, to extend the article into book-length form, or to otherwise re-use portions or excerpts in other works, with full acknowledgement of its original publication in the journal;
- may reproduce or authorize others to reproduce the article, material extracted from the article, or derivative works for the author's personal use or for company use, provided that the source and the copyright notice are indicated, the copies are not used in any way that implies JSCRTE endorsement of a product or service of any employer, and the copies themselves are not offered for sale.
All copies, print or electronic, or other use of the paper or article must include the appropriate bibliographic citation for the article's publication in the journal.
2. Requests from third parties
Although authors are permitted to re-use all or portions of the article in other works, this does not include granting third-party requests for reprinting, republishing, or other types of re-use. Requests for all uses not included above, including the authorization of third parties to reproduce or otherwise use all or part of the article (including figures and tables), should be referred to JSCRTE by going to our website at http://e-journal.unair.ac.id/index.php/JSCRTE
3. Author Online Use
- Personal Servers. Authors and/or their employers shall have the right to post the accepted version of articles pre-print version of the article, or revised personal version of the final text of the article (to reflect changes made in the peer review and editing process) on their own personal servers or the servers of their institutions or employers without permission from JSCRTE, provided that the posted version includes a prominently displayed JSCRTE copyright notice and, when published, a full citation to the original publication, including a link to the article abstract in the journal homepage. Authors shall not post the final, published versions of their papers;
- Classroom or Internal Training Use. An author is expressly permitted to post any portion of the accepted version of his/her own articles on the author's personal web site or the servers of the author's institution or company in connection with the author's teaching, training, or work responsibilities, provided that the appropriate copyright, credit, and reuse notices appear prominently with the posted material. Examples of permitted uses are lecture materials, course packs, e-reserves, conference presentations, or in-house training courses;
- Electronic Preprints. Before submitting an article to an JSCRTE, authors frequently post their manuscripts to their own web site, their employer's site, or to another server that invites constructive comment from colleagues. Upon submission of an article to JSCRTE, an author is required to transfer copyright in the article to JSCRTE, and the author must update any previously posted version of the article with a prominently displayed JSCRTE copyright notice. Upon publication of an article by the JSCRTE, the author must replace any previously posted electronic versions of the article with either (1) the full citation to the work with a Digital Object Identifier (DOI) or link to the article abstract in JSCRTE homepage, or (2) the accepted version only (not the final, published version), including the JSCRTE copyright notice and full citation, with a link to the final, published article in journal homepage.
4. Articles in Press (AiP) service
JSCRTE may choose to publish an abstract or portions of the paper before we publish it in the journal. Please contact our Production department immediately if you do not want us to make any such prior publication for any reason, including disclosure of a patentable invention.
5. Author/Employer Rights
If you are employed and prepared the article on a subject within the scope of your employment, the copyright in the article belongs to your employer as a work-for-hire. In that case, JSCRTE assumes that when you sign this Form, you are authorized to do so by your employer and that your employer has consented to the transfer of copyright, to the representation and warranty of publication rights, and to all other terms and conditions of this Form. If such authorization and consent has not been given to you, an authorized representative of your employer should sign this Form as the Author.
6. JSCRTE Copyright Ownership
It is the formal policy of JSCRTE to own the copyrights to all copyrightable material in its technical publications and to the individual contributions contained therein, in order to protect the interests of the JSCRTE, its authors and their employers, and, at the same time, to facilitate the appropriate re-use of this material by others. JSCRTE distributes its technical publications throughout the world and does so by various means such as hard copy, microfiche, microfilm, and electronic media. It also abstracts and may translate its publications, and articles contained therein, for inclusion in various compendiums, collective works, databases and similar publications
Every accepted manuscript should be accompanied by "Copyright Transfer Agreement" prior to the article publication.
